Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (40202) 40202
Newspaper Article (529) 529
Magazine Article (477) 477
Book Chapter (378) 378
Newsletter (305) 305
Book / eBook (122) 122
Conference Proceeding (59) 59
Government Document (42) 42
Dissertation (40) 40
Web Resource (23) 23
Publication (21) 21
Trade Publication Article (9) 9
Reference (6) 6
Book Review (5) 5
Streaming Video (5) 5
Video Recording (5) 5
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (32514) 32514
female (29653) 29653
science & technology (24674) 24674
life sciences & biomedicine (23344) 23344
middle aged (11864) 11864
estrogen (9882) 9882
breast cancer (9191) 9191
biological and medical sciences (8823) 8823
adult (8703) 8703
medical sciences (8150) 8150
animals (8063) 8063
oncology (7987) 7987
aged (7951) 7951
estrogens - therapeutic use (7385) 7385
breast neoplasms - drug therapy (7143) 7143
estrogens (6817) 6817
male (6630) 6630
menopause (4981) 4981
breast neoplasms - pathology (4898) 4898
receptors, estrogen - metabolism (4593) 4593
tumors (4451) 4451
cancer (4426) 4426
abridged index medicus (4072) 4072
breast neoplasms - metabolism (4039) 4039
tamoxifen - therapeutic use (3687) 3687
pharmacology. drug treatments (3577) 3577
risk factors (3513) 3513
estrogen replacement therapy (3502) 3502
health aspects (3426) 3426
obstetrics & gynecology (3357) 3357
research (3205) 3205
prognosis (3149) 3149
gynecology. andrology. obstetrics (3121) 3121
care and treatment (3084) 3084
treatment outcome (3079) 3079
analysis (2865) 2865
endocrinology & metabolism (2701) 2701
pharmacology & pharmacy (2698) 2698
mice (2679) 2679
rats (2649) 2649
medicine & public health (2589) 2589
antineoplastic agents, hormonal - therapeutic use (2584) 2584
chemotherapy (2480) 2480
postmenopause (2449) 2449
tamoxifen (2444) 2444
breast neoplasms - genetics (2431) 2431
gene expression (2421) 2421
hormone replacement therapy (2366) 2366
receptors, estrogen - analysis (2250) 2250
estrogen antagonists - therapeutic use (2216) 2216
progesterone (2203) 2203
hormones (2186) 2186
aged, 80 and over (2172) 2172
estradiol - therapeutic use (2085) 2085
pregnancy (2078) 2078
selective estrogen receptor modulators - therapeutic use (2002) 2002
receptors, progesterone - metabolism (1951) 1951
mammary gland diseases (1946) 1946
research article (1933) 1933
estrogen receptors (1901) 1901
antineoplastic combined chemotherapy protocols - therapeutic use (1897) 1897
osteoporosis (1863) 1863
cell line, tumor (1859) 1859
immunohistochemistry (1830) 1830
time factors (1779) 1779
phenols (1752) 1752
estrogen receptor (1750) 1750
antineoplastic agents - therapeutic use (1745) 1745
women (1743) 1743
estradiol (1738) 1738
estrogens - pharmacology (1733) 1733
ovariectomy (1720) 1720
medicine (1686) 1686
proteins (1672) 1672
postmenopausal women (1661) 1661
physiological aspects (1651) 1651
estradiol - pharmacology (1643) 1643
estrogens - metabolism (1610) 1610
drug therapy (1606) 1606
hormone therapy (1578) 1578
follow-up studies (1566) 1566
antineoplastic agents (1560) 1560
breast neoplasms - mortality (1543) 1543
general & internal medicine (1542) 1542
receptor, erbb-2 - metabolism (1513) 1513
adolescent (1502) 1502
cell biology (1502) 1502
retrospective studies (1498) 1498
womens health (1497) 1497
metastasis (1489) 1489
medicine, general & internal (1482) 1482
neoplasm staging (1469) 1469
chemotherapy, adjuvant (1423) 1423
biochemistry & molecular biology (1412) 1412
genetic aspects (1391) 1391
progestins - therapeutic use (1388) 1388
estrogens - adverse effects (1384) 1384
neurosciences & neurology (1374) 1374
apoptosis (1364) 1364
dose-response relationship, drug (1343) 1343
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (88) 88
Online Resources - Online (24) 24
New College (Ivey) - Stacks (16) 16
Collection Dvlpm't (Acquisitions) - Vendor file (13) 13
Collection Dvlpm't (Acquisitions) - Closed Orders (12) 12
UTL at Downsview - May be requested (6) 6
UofT at Mississauga - Stacks (6) 6
Media Commons - Audio Visual (5) 5
OISE - Stacks (2) 2
Scarborough Hospital - General (2) 2
St. Michael's Hospital - Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Baycrest Hospital - Wellness Library (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Providence Healthcare - Stacks (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - Online (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (38830) 38830
German (1078) 1078
French (780) 780
Japanese (630) 630
Russian (282) 282
Italian (281) 281
Spanish (239) 239
Chinese (163) 163
Polish (124) 124
Portuguese (78) 78
Danish (58) 58
Dutch (58) 58
Czech (56) 56
Hungarian (50) 50
Norwegian (44) 44
Bulgarian (42) 42
Swedish (38) 38
Finnish (33) 33
Hebrew (30) 30
Croatian (16) 16
Romanian (15) 15
Ukrainian (14) 14
Serbian (9) 9
Slovak (9) 9
Afrikaans (5) 5
Korean (4) 4
Lithuanian (3) 3
Turkish (3) 3
Arabic (1) 1
Armenian (1) 1
Bosnian (1) 1
Persian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Concurrent new drug prescriptions and prognosis of early breast cancer: studies using the Danish Breast Cancer Group clinical database
by Cronin-Fenton, Deirdre and Lash, Timothy L and Ahern, Thomas P and Damkier, Per and Christiansen, Peer and Ejlertsen, Bent and Sørensen, Henrik T
Acta oncologica, ISSN 0284-186X, 01/2018, Volume 57, Issue 1, pp. 120 - 128
Life Sciences & Biomedicine | Oncology | Science & Technology | Simvastatin - therapeutic use | Glucocorticoids - therapeutic use | Prognosis | Humans | Neoplasm Recurrence, Local | Serotonin Uptake Inhibitors - therapeutic use | Analgesics, Opioid - therapeutic use | Disease Progression | Cardiotonic Agents - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Estrogen Antagonists - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Breast Neoplasms - pathology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Tamoxifen - therapeutic use | Cyclooxygenase 2 Inhibitors - therapeutic use | Denmark | Female | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Digoxin - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Databases, Factual | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Preventive therapy for breast cancer: a consensus statement
by Cuzick, Jack, Prof and DeCensi, Andrea, MD and Arun, Banu, Prof and Brown, Powel H, Prof and Castiglione, Monica, Prof and Dunn, Barbara, MD and Forbes, John F, Prof and Glaus, Agnes, PhD and Howell, Anthony, Prof and von Minckwitz, Gunter, Prof and Vogel, Victor, MD and Zwierzina, Heinz, Prof
The lancet oncology, ISSN 1470-2045, 2011, Volume 12, Issue 5, pp. 496 - 503
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Thiophenes - therapeutic use | Metformin - therapeutic use | Raloxifene Hydrochloride - therapeutic use | Humans | Selective Estrogen Receptor Modulators - adverse effects | Tetrahydronaphthalenes - therapeutic use | Pyrrolidines - therapeutic use | Antineoplastic Agents, Hormonal - adverse effects | Aromatase Inhibitors - adverse effects | Estrogen Receptor Modulators - therapeutic use | Retinoids - therapeutic use | Selective Estrogen Receptor Modulators - therapeutic use | Antineoplastic Agents, Hormonal - therapeutic use | Diphosphonates - therapeutic use | Female | Aromatase Inhibitors - therapeutic use | Estrogen Receptor Modulators - adverse effects | Anticarcinogenic Agents - therapeutic use | Triazoles - therapeutic use | Premenopause | Anastrozole | Consensus Development Conferences as Topic | Breast Neoplasms - prevention & control | Fenretinide - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Piperidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Tamoxifen - therapeutic use | Androstadienes - therapeutic use | Expert Testimony | Norpregnenes - therapeutic use | Nitriles - therapeutic use | COX-2 inhibitors | Care and treatment | Aspirin | Oncology, Experimental | Menopause | Phosphonates | Breast cancer | Retinoids | Research | Tamoxifen | Prevention | Analysis | Health aspects | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline
by Eastell, Richard and Rosen, Clifford J and Black, Dennis M and Cheung, Angela M and Murad, M Hassan and Shoback, Dolores
The journal of clinical endocrinology and metabolism, ISSN 0021-972X, 05/2019, Volume 104, Issue 5, pp. 1595 - 1622
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Estrogen Replacement Therapy | Raloxifene Hydrochloride - therapeutic use | Teriparatide - therapeutic use | Risk Assessment | Risk Reduction Behavior | Humans | Osteoporotic Fractures - prevention & control | Bone Density Conservation Agents - therapeutic use | Calcitonin - therapeutic use | Patient Preference | Absorptiometry, Photon | Osteoporosis, Postmenopausal - drug therapy | Denosumab - therapeutic use | Parathyroid Hormone-Related Protein - therapeutic use | Estrogen Receptor Modulators - therapeutic use | Accidental Falls - prevention & control | Selective Estrogen Receptor Modulators - therapeutic use | Calcium - therapeutic use | Clinical Decision-Making | Osteoporosis, Postmenopausal - diagnostic imaging | Diphosphonates - therapeutic use | Female | Vitamin D - therapeutic use | Norpregnenes - therapeutic use | Cost-benefit analysis | Osteoporosis | Fractures | Decision making | Clinical trials | Hormone replacement therapy | Clinical medicine | Management | Patients | Post-menopause | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Role of Medical Management for Uterine Leiomyomas
by Kashani, Banafsheh N., MD and Centini, Gabriele, MD and Morelli, Sara S., MD and Weiss, Gerson, MD and Petraglia, Felice, MD
Best practice & research. Clinical obstetrics & gynaecology, ISSN 1521-6934, 2015, Volume 34, pp. 85 - 103
Obstetrics and Gynecology | uterine leiomyomas | medical management | abnormal uterine bleeding | fibroids | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Antifibrinolytic Agents - therapeutic use | Contraceptive Agents, Female - therapeutic use | Contraceptives, Oral, Synthetic - therapeutic use | Humans | Contraceptive Agents, Female - administration & dosage | Dopamine Agonists - therapeutic use | Estrenes - therapeutic use | Oximes - therapeutic use | Intrauterine Devices, Medicated | Patient Care Planning | Selective Estrogen Receptor Modulators - therapeutic use | Cholecalciferol - therapeutic use | Female | Gestrinone - therapeutic use | Aromatase Inhibitors - therapeutic use | Gonadotropin-Releasing Hormone - agonists | Danazol - therapeutic use | Contraceptives, Oral, Hormonal - therapeutic use | Somatostatin - analogs & derivatives | Norpregnadienes - therapeutic use | Gonadotropin-Releasing Hormone - antagonists & inhibitors | Tranexamic Acid - therapeutic use | Vitamins - therapeutic use | Ergolines - therapeutic use | Estrogen Antagonists - therapeutic use | Levonorgestrel - administration & dosage | Leiomyoma - drug therapy | Uterine Neoplasms - drug therapy | Mifepristone - therapeutic use | Fluocinolone acetonide | Pituitary hormones | Progesterone | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text An Evidence-based Approach to the Medical Management of Fibroids: A Systematic Review
by BARTELS, CHANTAL B and CAYTON, KAMARIA C and CHUONG, FARAH S and HOLTHOUSER, KRISTINE and MEHR, SARA A and ABRAHAM, TARA and SEGARS, JAMES H
Clinical obstetrics and gynecology, ISSN 0009-9201, 03/2016, Volume 59, Issue 1, pp. 30 - 52
Leiomyoma | Medical therapy | Fibroids | Medical treatment | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Estradiol - analogs & derivatives | Contraceptive Agents, Female - therapeutic use | Humans | Estrenes - therapeutic use | Oximes - therapeutic use | Receptors, Progesterone - antagonists & inhibitors | Intrauterine Devices, Medicated | Selective Estrogen Receptor Modulators - therapeutic use | Estrogen Receptor Antagonists - therapeutic use | Androgens - therapeutic use | Female | Neoadjuvant Therapy | Curcumin | Aromatase Inhibitors - therapeutic use | Drugs, Chinese Herbal - therapeutic use | Gonadotropin-Releasing Hormone - agonists | Uterine Neoplasms - prevention & control | Estradiol - therapeutic use | Norpregnadienes - therapeutic use | Medroxyprogesterone Acetate - therapeutic use | Gonadotropin-Releasing Hormone - antagonists & inhibitors | Evidence-Based Medicine | Uterine Myomectomy | Vitamins - therapeutic use | Leiomyoma - prevention & control | Contraceptives, Oral, Combined - therapeutic use | Tea | Leiomyoma - drug therapy | Uterine Neoplasms - drug therapy | Levonorgestrel - therapeutic use | Hormone Antagonists - therapeutic use | Vitamin D - therapeutic use | Delayed-Action Preparations | Plant Extracts - therapeutic use | Mifepristone - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights